QA: Aptinyx Inc in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001674365_2022_Aptinyx_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001674365, Aptinyx Inc

  xvar xval
0 AssetsCurrent 114,743,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 185,000
3 remainder_Assets 0
4 LiabilitiesCurrent 5,686,000
5 LiabilitiesNoncurrent 14,486,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 20,508,875
9 ResearchAndDevelopmentExpense 52,186,983
10 remainder_Expenses 0
11 remainder_Revenues 1,098,038
12 remainder_NetIncome -852,848
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 114,928,000
1 Liabilities 20,172,000
2 Expenses 72,695,858
3 Revenues 1,098,038
4 StockholdersEquity 94,756,000
5 NetIncome -72,450,668
6 ComprehensiveNetIncome -72,450,668
7 BaseVar 104,873,372
8 EconomicCapitalRatiobeforeLimitedLiability 1.99
9 EconomicCapitalRatio 3.01

Edgar->Model Mapping

Feature Distribution

Change over Time